Impaired clearance of apoptotic cardiocytes is linked to anti-SSA/Ro and -SSB/La antibodies in the pathogenesis of congenital heart block.

Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0021-9738 (Print) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE

Publication: 1999- : Ann Arbor, MI : American Society for Clinical Investigation
Original Publication: New Haven [etc.] American Society for Clinical Investigation.

Apoptosis/*physiology ; Autoantigens/*immunology ; Heart/*embryology ; Heart Block/*physiopathology ; Heart Defects, Congenital/*physiopathology ; Myocardium/*pathology ; Ribonucleoproteins/*immunology; Animals ; Antibodies, Monoclonal ; Cell Membrane/physiology ; Cell Nucleus/physiology ; Child ; Female ; Fetal Development ; Heart/physiology ; Heart Block/immunology ; Heart Block/pathology ; Heart Defects, Congenital/immunology ; Heart Defects, Congenital/pathology ; Humans ; Immunoglobulin G/blood ; Immunoglobulin G/isolation & purification ; Mice ; Reference Values ; fas Receptor/physiology ; SS-B Antigen

The role of cardiocytes in physiologic removal of apoptotic cells and the subsequent effect of surface binding by anti-SSA/Ro and -SSB/La antibodies was addressed. Initial experiments evaluated induction of apoptosis by extrinsic and intrinsic pathways. Nuclear injury and the translocation of SSA/Ro and SSB/La antigens to the fetal cardiocyte plasma membrane were common downstream events of Fas and TNF receptor ligation, requiring caspase activation. As assessed by phase-contrast and confirmed by confocal microscopy, coculturing of healthy cardiocytes with cardiocytes rendered apoptotic via extrinsic pathways revealed a clearance mechanism that to our knowledge has not previously been described. Cultured fetal cardiocytes expressed phosphatidylserine receptors (PSRs), as did cardiac tissue from a fetus with congenital heart block (CHB) and an age-matched control. Phagocytic uptake was blocked by anti-PSR antibodies and was significantly inhibited following preincubation of apoptotic cardiocytes with chicken and murine anti-SSA/Ro and -SSB/La antibodies, with IgG from an anti-SSA/Ro- and -SSB/La-positive mother of a CHB child, but not with anti-HLA class I antibody. In a murine model, anti-Ro60 bound and inhibited uptake of apoptotic cardiocytes from wild-type but not Ro60-knockout mice. Our results suggest that resident cardiocytes participate in physiologic clearance of apoptotic cardiocytes but that clearance is inhibited by opsonization via maternal autoantibodies, resulting in accumulation of apoptotic cells, promoting inflammation and subsequent scarring.

J Immunol. 1998 Dec 1;161(11):5886-92. (PMID: 9834068)
Cell Death Differ. 2006 Oct;13(10):1715-26. (PMID: 16470225)
Curr Opin Immunol. 2000 Feb;12(1):27-34. (PMID: 10679400)
Nature. 2000 May 4;405(6782):85-90. (PMID: 10811223)
Nature. 2000 Oct 12;407(6805):784-8. (PMID: 11048729)
J Immunol. 2000 Nov 1;165(9):5345-51. (PMID: 11046070)
Development. 2000 Dec;127(24):5245-52. (PMID: 11076747)
Neurology. 2001 Jun 12;56(11):1606-7. (PMID: 11409415)
J Clin Invest. 2001 Oct;108(7):957-62. (PMID: 11581295)
Curr Biol. 2001 Oct 2;11(19):R795-805. (PMID: 11591341)
Arthritis Rheum. 2002 Jan;46(1):202-8. (PMID: 11817591)
Nature. 2002 May 9;417(6885):182-7. (PMID: 12000961)
Arthritis Rheum. 2002 Jun;46(6):1572-9. (PMID: 12115188)
J Immunol. 2002 Aug 15;169(4):2156-63. (PMID: 12165545)
J Autoimmun. 2002 Aug-Sep;19(1-2):79-86. (PMID: 12367562)
Dev Cell. 2003 Apr;4(4):587-98. (PMID: 12689596)
Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7503-8. (PMID: 12788971)
Arthritis Rheum. 2003 Jul;48(7):2080-2; author reply 2082-3. (PMID: 12847710)
J Immunol. 2003 Sep 15;171(6):3296-302. (PMID: 12960360)
J Immunol. 2003 Dec 1;171(11):5778-86. (PMID: 14634086)
Science. 2003 Nov 28;302(5650):1560-3. (PMID: 14645847)
J Leukoc Biol. 2003 Dec;74(6):959-60. (PMID: 12960252)
Semin Arthritis Rheum. 2003 Dec;33(3):140-54. (PMID: 14671725)
Arthritis Rheum. 2004 Jan;50(1):173-82. (PMID: 14730614)
Arthritis Rheum. 2004 Jan;50(1):337-8; author reply 338. (PMID: 14730639)
Anat Rec A Discov Mol Cell Evol Biol. 2004 Apr;277(2):355-69. (PMID: 15052663)
J Immunol Methods. 1990 May 25;129(2):207-10. (PMID: 2351837)
Mol Biol Rep. 1990;14(2-3):53. (PMID: 2113989)
J Immunol. 1994 Apr 1;152(7):3675-84. (PMID: 7511655)
J Exp Med. 1994 Apr 1;179(4):1317-30. (PMID: 7511686)
Cell. 1995 May 19;81(4):495-504. (PMID: 7758105)
Cell. 1995 May 19;81(4):505-12. (PMID: 7538907)
Cell. 1996 Jun 14;85(6):803-15. (PMID: 8681376)
Cell. 1996 Jun 14;85(6):817-27. (PMID: 8681377)
J Exp Med. 1998 Feb 16;187(4):587-600. (PMID: 9463409)
J Clin Invest. 1998 Feb 15;101(4):890-8. (PMID: 9466984)
J Am Coll Cardiol. 1998 Jun;31(7):1658-66. (PMID: 9626848)
Kobe J Med Sci. 1997 Oct;43(5):143-57. (PMID: 9642970)
J Immunol. 1998 Jul 1;161(1):241-51. (PMID: 9647230)
Pediatr Res. 1998 Jul;44(1):11-9. (PMID: 9667364)
J Immunol. 1998 Nov 1;161(9):5061-9. (PMID: 9794444)
Pediatr Res. 1999 Feb;45(2):260-9. (PMID: 10022600)
Ann Surg. 2005 Jan;241(1):144-51. (PMID: 15622002)
J Exp Med. 2005 Jan 3;201(1):11-7. (PMID: 15630133)
Cell Death Differ. 2005 Feb;12(2):107-14. (PMID: 15647754)
Arthritis Rheum. 2005 Dec;52(12):3934-42. (PMID: 16320341)
Arthritis Rheum. 2006 Mar;54(3):939-50. (PMID: 16511837)
J Cell Biol. 1999 Jan 25;144(2):281-92. (PMID: 9922454)

AR-42455 United States AR NIAMS NIH HHS; R01 AR042455 United States AR NIAMS NIH HHS; P30 AR047360 United States AR NIAMS NIH HHS; P30 AR47360 United States AR NIAMS NIH HHS; R37 AR042455 United States AR NIAMS NIH HHS; AR-4-2271 United States AR NIAMS NIH HHS

0 (Antibodies, Monoclonal)
0 (Autoantigens)
0 (Immunoglobulin G)
0 (Ribonucleoproteins)
0 (SS-A antigen)
0 (fas Receptor)

Date Created: 20060815 Date Completed: 20061030 Latest Revision: 20231213

20231215

PMC1533875

10.1172/JCI27803

16906225